Our results show that cisplatin-resistant ovarian cancer cell lines upregulate HSP27 and FAO to deplete cisplatin-induced ROS to attenuate cisplatin’s cytotoxic effect. This evidence concerns the gene HSPB1 and ovarian carcinoma.